Cidara Therapeutics, Inc. (CDTX)

Merck is acquiring Cidara Therapeutics for $9.2 billion, boosting CDTX's stock significantly. The company also secured a BARDA award and FDA Breakthrough Therapy Designation for its influenza treatment.

About Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics, particularly for influenza.
Cidara Therapeutics, Inc. uses the ticker $CDTX for trading. Listed in the Stocks category.

Insights

Cidara Therapeutics, Inc. (CDTX) market dominance near a 52-week low at [-------].
Cidara Therapeutics, Inc. (CDTX) social dominance is up 150% from the previous week.
Cidara Therapeutics, Inc. (CDTX) creators is up 20.68% from the previous month.
Cidara Therapeutics, Inc. (CDTX) engagements is up 10.64% from the previous week.
Cidara Therapeutics, Inc. (CDTX) mentions is up 16.82% from the previous month.
Cidara Therapeutics, Inc. (CDTX) posts created is up 416.67% from the previous week.

Price: $221.40

Price 24-Hour Time-Series Raw Data
The stock price has surged dramatically, driven by the confirmation of a $9.2 billion acquisition by Merck, alongside a BARDA award, FDA Breakthrough Therapy Designation, and analyst upgrades. Increased social media discussions are amplifying these upward trends.

24-Hour: 0.03%

1-Year High: $221.40 on 2026-01-06
1-Year Low: $16.40 on 2025-04-04

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Cidara Therapeutics, Inc. (CDTX) is currently AltRank #1,803 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [-----] [----]
[--] Month: [-----] +409
[--] Months: [-----] +1,160
[--] Year: [-----] +129
1-Year High: [-----] on 2026-02-05
1-Year Low: [--] on 2025-08-16

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +3
[--] Month: [--] [---]
1-Year High: [--] on 2025-12-22
1-Year Low: [--] on 2026-02-01

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [------]
[--] Week: [------] +11%
[--] Month: [------] -62%
[--] Months: [---------] +94%
[--] Year: [---------] +1,738%
1-Year High: [---------] on 2025-11-14
1-Year Low: [--] on 2025-02-23

Engagements by network (24h): X: [---] News: [--] Reddit: [--] TikTok: [--] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [---]
[--] Week: [---] +11%
[--] Month: [---] +17%
[--] Months: [-----] -22%
[--] Year: [------] +2,534%
1-Year High: [-----] on 2025-06-24
1-Year Low: [--] on 2025-04-13

Mentions by network (24h): X: [--] News: [--] Reddit: [--] TikTok: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Cidara Therapeutics, Inc. (CDTX) in the last [--] hours which is down 24% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +14%
[--] Month: [---] +21%
[--] Months: [-----] -27%
[--] Year: [-----] +2,295%
1-Year High: [-----] on 2025-06-23
1-Year Low: [--] on 2025-04-13

The most influential creators that mention Cidara Therapeutics, Inc. in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@AlmightyZeezA	[--]	[---]	[--]	[--]
@BiopharmIQ	[--]	[------]	[--]	[--]

Sentiment: 71%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 71%
Daily Average: 81%
[--] Week: 100% no change
[--] Month: 67% -1%
[--] Months: 67% -31%
[--] Year: 67% +17%
1-Year High: 100% on 2025-02-23
1-Year Low: 33% on 2025-03-13

Most Supportive Themes:

Analyst Ratings: (10%) JP Morgan initiated coverage on Cidara Therapeutics with an Overweight rating and a $200 price target.
BARDA Award: (8%) Cidara Therapeutics received a substantial BARDA award to support manufacturing and clinical development of CD388.
FDA Breakthrough Therapy Designation: (7%) The FDA granted Breakthrough Therapy Designation to CD388 for the prevention of seasonal influenza.

Most Critical Themes:

Valuation Concerns: (5%) Some analysts express concern about the current valuation of $CDTX, with one noting it seems expensive at a $4.3 billion market cap and that Phase [--] trials could fail.

Social Dominance: 0.0023%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0023%
Daily Average: 0.018%
[--] Week: 0.0025% +0.0015%
[--] Month: 0.0052% -0.0023%
[--] Months: 0.0052% -0.0098%
[--] Year: 0.0052% +0.0022%
1-Year High: 0.384% on 2025-06-24
1-Year Low: 0.0002% on 2025-04-13

Market Dominance: 0.00789%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00789%
Daily Average: 0%
1-Year High: 0.241% on 2025-12-19
1-Year Low: 0.00779% on 2026-02-02

Top Cidara Therapeutics, Inc. Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"☀ Updated list of TRIPLE & QUADRUPLE digits % gainer MULTI BAGGERS from me in last [--] yr ☀ $LAES - UP 2800+% $LUNRW - UP 1500+% $RKLB - UP 1200% $LITM - UP 1150% $OPTT - UP 1000+% $RR - UP 850% $ATNFW - UP 800% $GNPX - UP 700+% $CDTX - UP 650% $LUNR - UP 600+% $MOB - UP 600% $WKEY - UP 600% $AAOI - UP 550% $SKVI - UP 500% $GRI - UP 450% $HOVR - UP 400% $HOUR - UP 400% $HOVRW - UP 400% $SNOA - UP 375% $GNLX - UP 300+% $RNAZ - UP 300+% $EDBLW - UP 300+% $NUKK - UP 275% $IINN - UP 250% $TSSI - UP 250% $USAR - UP 225% $ALLR - UP 225% $CINGW - UP 225% $PRLD - UP 200+% $BMXI - UP 200+% $SOAR - UP"
X Link @SuperDuperInvst 2025-11-04T01:10Z 63.9K followers, 97.1K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing